Pharmacovigilance (PV or PhV), also known as drug safety, is science and activities relating to the collection, detection, assessment, understanding, monitoring, and prevention of adverse effects or any other drug-related problem. Pharmacovigilance activities are performed across all phases of drug development, including preclinical studies, phase I to phase III trials, and phase IV or post market surveillance stages. Information received from patients and healthcare providers, as well as other sources such as the medical literature, plays a critical role in providing the data necessary for Pharmacovigilance. It is more concerned with identifying the hazards associated with pharmaceutical products and with minimizing the risk of any harm that may come to patients.
The global Pharmacovigilance market report estimates the market size (Revenue US$ million – 2014 to 2021) for key market segments based on the methods (cohort event monitoring, intensified ADRs reporting, spontaneous reporting, targeted spontaneous reporting and EHRs mining), service types (contact or outsourcing and in-house), pipeline analysis of clinical phases 1, 2, 3 and 4 (post marketing surveillance), and forecasts growth trends (CAGR% – 2017 to 2021).
The global Pharmacovigilance market report also provides the detailed market landscape, market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global Pharmacovigilance market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
Major players operating in the global Pharmacovigilance market and included in this report are Accenture, Plc, Clinquest Group B.V., Cognizant Technology Solutions, Covance, Inc. ICON, Plc, iMED Global Corporation, inVentiv Health, Inc., Parexel International Corporation, Pharmaceutical Product Development LLC, PRA Health Sciences, Inc., Quintiles Transnational Holdings Inc, F. Hoffmann-La Roche Ltd., Sanofi, Synowledge LLC, Wipro Limited.